Volume 31, Number 7—July 2025
Synopsis
Human Streptococcus suis Infections, South America, 1995–2024
Table 2
Characteristics of patients and isolates for the 8 new cases of human Streptococcus suis infection from Argentina, South America, 2017–2024*
Year | Patient |
Isolate |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age, y/sex | Disease | Contact with swine or pork | Outcome | Notes | Isolate ID | Source | Serotype | ST | Virulence markers | |||
2017 |
42/M |
NVE |
Yes, pig farmer |
Survived |
None |
26-17 |
Blood |
Untypable† |
1 |
mrp, epf, sly |
||
2018 |
1/F |
Meningitis |
Unknown, lived in rural area |
Survived |
None |
868-18 |
Blood |
2 |
1 |
mrp, epf, sly |
||
2019 |
Adult/M‡ |
Meningitis |
Unknown |
Survived |
None |
724-19 |
CSF |
2 |
1 |
mrp, epf, sly |
||
2020 |
38/M |
Meningitis |
No, lived in urban area |
Survived |
Inhalation drug user |
247-20 |
Blood, CSF§ |
2 |
1 |
mrp, epf, sly |
||
2021 |
47/M |
Meningitis |
Yes, consumed pork |
Survived |
Wild boar hunter |
521-21 |
Blood, CSF§ |
2 |
1 |
mrp, epf, sly |
||
2022 |
48/M |
Meningitis |
Yes, consumed pork |
Survived |
Wild boar hunter |
395-22 |
CSF |
2 |
1 |
mrp, epf, sly |
||
2022 |
45/M |
Meningitis |
Yes, handled not commercial pig |
Survived |
None |
931-22 |
CSF |
2 |
1 |
mrp, epf, sly |
||
2024 | 55/M | STSLS | Yes | Died | None | 649-24 | Blood | 2 | 1 | mrp, epf, sly |
*CSF, cerebrospinal fluid; epf extracellular protein factor; ID, identification; mrp, muramidase released protein; NVE, native valve endocarditis; sly, suilysin; ST, sequence type as defined by multilocus sequence typing; STSLS, streptococcal toxic shock–like syndrome. †Untypable by both serologic and molecular methods. ‡Precise age not available. §Only the isolate recovered from CSF was included in this investigation, although both were typed.
Page created: May 08, 2025
Page updated: June 25, 2025
Page reviewed: June 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.